Chimerix, Inc., a developing-stage biopharmaceutical company, focuses on accelerating the advancement of various drugs that impact the lives of patients living with cancer and other serious diseases. The company is headquartered in Durham, North Carolina. Show more

2505 MERIDIAN PARKWAY, DURHAM, NC, UNITED STATES, 27713, Durham, NC, 27713, USA

BIOTECHNOLOGY
HEALTHCARE

Market Cap

801.1M

52 Wk Range

$0.00 - $0.00

Previous Close

$8.54

Open

$8.54

Volume

N/A

Day Range

$8.54 - $8.54

Enterprise Value

0.00

Cash

31.05M

Avg Qtr Burn

-19.27M

Insider Ownership

1.73%

Institutional Own.

56.44%

Qtr Updated

03/31/25